DDW TV sat down with Jennifer A. Christie, MD, FASGE, moderator of this important session at DDW 2017. Dr. Christie says while all clinicians know the
DDW TV spoke with speaker Michael W. Fried, MD, FAASLD, about the incredible strides made in the treatment of hepatitis C – and how to
DDW TV spoke to session speaker, Ross F. Goldberg, MD, FACS, about the updates in MACRA and MIPS, the update in quality metrics, and we
Studies have shown that success in losing weight is affected by how often patients see a health-care professional. Patients benefit from the doctor’s advice and
People fighting obesity often look for treatments that will quickly help them lose weight. Lately, an increasing number are achieving that goal by having intragastric
Two new strategies are emerging to treat GI and other cancers — engineered T cells and immune checkpoint blockade treatments.
Andrew P. Keaveny, MD, FRCPI, FAASLD
Consultant Hepatologist and Medical Director of Liver Transplant, Mayo Clinic, Jacksonville, Florida; Associate Professor of Medicine, Mayo Clinic College of Medicine and Science; Chair, AASLD Annual Meeting Education Committee; Member of the AASLD Maintenance of Certification and Scientific Planning Committees
CRC screening guidelines vary around the world. The U.S. is one of the only countries, for example, that relies heavily on colonoscopies for CRC screening in average-risk populations. Other countries tend to rely on less expensive and less invasive screening technologies for average-risk screening.
The ASGE International Program at DDW® culminates on Tuesday with four joint symposia, including concurrent sessions with the Australian Gastrointestinal Endoscopy Association (AGEA) and the Chinese Society of Gastroenterology (CSGE).
Clostridium difficile colitis does not happen in a vacuum. When, why and how C. diff populations explode and cause colitis is the result of a complex interplay among bacteria, human host, the gut microbiome and the environment.